8 INTERNATIONAL EFR CONGRESS VIENNA, AUSTRIA APRIL 4 … · BÉLA TELEKY, MD, FRCS President of the EFR IRENE KÜHRER, MD Secretary General of the EFR Call for Abstracts 8TH INTERNATIONAL

BÉLA TELEKY, MD, FRCSPresident of the EFR

IRENE KÜHRER, MD

Secretary General of the EFR

www.efrcancer.org Call for Abstracts

8TH INTERNATIONAL EFR CONGRESSVIENNA, AUSTRIA

APRIL 4TH – 6TH, 2013

10TH ANNIVERSARY OF THE EFR –EUROPEAN FEDERATION FOR COLORECTAL CANCER

Programm_2013 15.01.13 15:30 Seite U1

3

Tab

le o

f C

ont

ent

TA B L E O F C O N T E N T

1. Welcome Letters 4

1.1. Béla Teleky, MD, FRCS, President of the EFR 4

2. Programme overview 5

3. Scientific programme 6

4. Speakers 13

5. Topics and Goals 14

6. General information 15

6.1. Scientific Secretariat 156.2. Registration 156.3. Exhibition 156.4. Location 157.5. Abstracts 15

Programm_2013 15.01.13 15:30 Seite 3

4

8T H INTERNATIONAL EFR CONGRESS

W E L C O M E M E S S A G E

It is a great pleasure and honour to invite you attending

the 8th EFR – European Federation for coloRectal

Cancer-Congress to be held from April 4th - 6th, 2013 at the

Medical University of Vienna. Following the success of the

previous conferences, the main objectives of this meeting

will be progress and future developments in the treatment of colorectal

cancer. The management of colorectal cancer requires a multidisciplinary

approach with individualized treatment concepts due to stage and risk

factors. The conference schedule will provide you with the latest data of

multimodality treatment and the optimization of different treatment compo-

nents. Abstract submitters will have the chance to present their works. The

best three abstracts will be selected and honoured by the Ingeborg Hörhager

Prize.

Vienna, also described as Europe’s cultural capital, is a metropolis with unique

charm, vibrancy and flair. As a clean and a safe city, it boasts outstanding

infrastruc ture and has all the inspiration that you could wish for in order to

discover this wonderful part of Europe, especially during the spring time.

We look forward to welcoming you to an inspiring congress in Vienna in 2013.

Béla Teleky, MD, FRCS

President of the EFR

Wel

com

e M

essa

ge

Programm_2013 15.01.13 15:30 Seite 4

5

P R O G R A M M E O V E R V I E W

THURSDAY, APRIL 4TH

12:00 – 12:30 Opening Ceremony

12:30 – 14:10 Session I

14:10 – 14:40 Coffee break

14:40 – 15:50 Session II

15:50 – 16:30 Consultant Corner:

16:30 – 17:30 ROCHE Symposium

17:45 Transfer to Welcome Reception to Schönbrunn

19:00 Guided Tour and Welcome Reception – Schönbrunn

FRIDAY, APRIL 5TH

08:30 – 10:00 Session III


10.30 – 12:00 Session IV

12:00 – 13:00SANOFI Lunch Symposium: Metastatic colorectal disease;new treatment options

13:00 – 14:40 Session V


15:00 – 16:30 Session VI

16:30 – 17:30MERCK Symposium: Conversion Therapy of Liver Metastases in the Light of ESMO-Guidelines

17:45Transfer to Stift Klosterneuburg Guided Tour –Networking Dinner

SATURDAY, APRIL 6TH

08:00 – 09:00 Breakfast Symposium STRYKER

09:00 – 10:30 Session VII


11:00 – 12:30 Session VIII

12:30 – 13:00 Hörhager Prize

13:00 Closing remarks Pro

gra

mm

e O

verv

iew

Programm_2013 15.01.13 15:30 Seite 5

6

Scie

ntifi

c P

rog

ram

me

S C I E N T I F I C P R O G R A M M E

THURSDAY, APRIL 4TH

12:00 – 12:30 Opening Ceremony

Rektor: W. SchützCCC: C. Zielinski

12:30 – 14:10 Session I

Moderation: J. NichollsChair: Andrea Maier, F. Wrba

B. Teleky: Opening 10 min

C. Van de Velde: Factors to determine the success of surgical procedures in colorectal cancer 20 min

F. Aigner: Anatomical considerations in TNM staging and therapeutical procedures for low rectal cancer 15 min

Gina Brown: Staging in Rectal Cancer: what is mandatory from a radiological point of view 15 min

Iris Nagtegaal: Staging in Rectal Cancer: what is mandatory from a pathological point of view

J. Hoch: Colorectal cancer in Central and Eastern Europe: Austrian-Hungary empire ancestry revealed?" 15 min

A. Dziki: Colorectal cancer in young patients 15 min

Discussion 10 min



Programm_2013 15.01.13 15:30 Seite 6

7

14:40 – 15:50 Session II

Moderation: C. StaudacherChair: M. Szczepkowski, J. Tschmelitsch

V. Fazio: Reoperative Pelvic Surgery Management of Advanced Rectal Cancer 15 min

L. Pahlman: New challenges in rectal cancer 15 min

P. Delrio: Transanal minimally invasive surgery for rectal tumours: new approaches 15min

Z. Krivokapic: T4 tumors – strategy of treatment 15 min

Discussion 10 min

15:50 – 16:30 Consultant Corner: 40 min

Moderation: G. Romano: Interactive case presentations

Consultant Corner:P. Delrio, V. Fazio, Z. Krivokapic, L. Pahlman, C. Staudacher,A. Stift, M. Szczepkowski, J. Tschmelitsch

16:30 – 17:30 ROCHE Symposium

17:45 Transfer to Welcome Reception to Schönbrunn

19:00 Guided Tour and Welcome Reception – Schönbrunn

Scie

ntifi

c P

rog

ram

me

Programm_2013 15.01.13 15:30 Seite 7

8

FRIDAY, APRIL 5TH

08:30 – 10:00 Session III

Moderation: J. LangeChair: R. Jakesz, Judith Karner-Hanusch

P. Paty: Non operative management of rectal cancer:the MSKCC Experience 15 min

F. Seow-Choen: Ethics and colorectal innovation 15 min

Y. Shelygin: Transanal endosopic surgery: current status and future 15 min

Th. Bachleitner-Hofmann: Genomic classifiers in planning of personalized treatment for stage II and III colon cancer 15 min

R. Madjov: Acute malignant large bowel obstruction: A decision making analysis 15 min

Discussion 15 min


10.30 – 12:00 Session IV

Moderation: D. ÖfnerChair: M. Gnant, G. Lázár

B. Heald: TME – still the focal point of progress in rectal cancer 15 min

Elena Orsenigo: Sphincter saving surgery in rectal: an evidence based analysis 15 min

A. Lacy: Transanal endoscopic surgery 15 min

R. Kennedy: Laparoscopic surgery - does it better? (Video) 20 min

Anna Martling: Patient tailored APE in low rectal cancer 15 min

Discussion 10 minScie

ntifi

c P

rog

ram

me


Programm_2013 15.01.13 15:30 Seite 8

9

Scie

ntifi

c P

rog

ram

me

12:00 – 13:00 SANOFI Lunch Symposium:

Metastatic colorectal disease; new treatment options

13:00 – 14:40 Session V

Moderation: R. SchiesselChair: L. Damjanovich, I. Karaitianos

R. Schiessel: Memorial lecture: 125 years of sphincter saving surgery 10 min

A. D’Hoore: Beyond laparoscopy: NOSE and TAMIS 15 min

J. Milsom: Defining new field of colorectal surgery – Standard methods and emerging technologies 15 min

E. Rybakov: Intersphincteric resection for rectal carcinoma - ultima ratio chirurgum 15 min

I. Popescu: The robotic approach in rectal cancer: indications, technique and results 15 min

K. Seon-Hahn: Minimally invasive surgery for rectal cancer: impact on treatment outcomes 15 min

Discussion 15 min


Programm_2013 15.01.13 15:30 Seite 9

10

15:00 – 16:30 Session VI

Moderation: MischingerChair: R. Steininger, M. Schindl

N. Lygidakis: Past, present and future of treatment of liver metastases following colorectal cancer 15 min

G. Poston: What are the limits in resection of colorectal liver metastases? 5 min

Th. Grünberger: Essential surgical treatment decisions for CLM 15 min

N. Kokudo: Surgical strategies for multiple colorectal liver mets: experience of ICG fluorescence diagnosis 15 min

M. Ryska: Surgery for liver metastases of colorectal carcinoma in Czech Republic: current national survey 15 min

Discussion 15 min

16:30 – 17:30 MERCK Symposium:

Conversion Therapy of Liver Metastases in the Light of ESMO-Guidelines

17:45 Transfer to Stift Klosterneuburg Guided Tour –Networking Dinner

Scie

ntifi

c P

rog

ram

me


Programm_2013 15.01.13 15:30 Seite 10

11

SADURDAY, APRIL 6TH

08:00 – 09:00 Breakfast Symposium STRYKER

09:00 – 10:30 Session VII

Moderation: Irene KührerChair: I. Pravosudov , R. Pötter

J. Korcek: Update D2 EUS in rectal cancer Preoperative staging, restaging after RTX 10 min

V. Valentini: How to tailor rectal cancer treatment by available prediction model 15 min

H. Becker: Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: survival benefit after a median follow-up of 11 years. 15 min

Z. Mammadli: Neoadjuvant chemoradiotherapy with different Fluoropyrimidine 10 min

N. Wasserberg: The interval between neoadjuvant treatment and surgery for rectal cancer 15 min

M. Omejc: Pathologic complete response after neoadjuvant chemoradiation in locally advanced rectal cancer 15 min

Discussion 10 min

10:30 – 11:00 Coffee breakSc

ient

ific

Pro

gra

mm

e

Programm_2013 15.01.13 15:30 Seite 11

12

Scie

ntifi

c P

rog

ram

me

11:00 – 12:30 Session VIII

Moderation: Gabriele KornekChair: Z. Saladzinskas, T. Skricka

J. Marshall: Value: the primary driver in cancer care and clinical research 15min

P. Sugarbaker: Perioperative chemotherapy for peritoneal metastases: Pharmacologic rationale and currentstandard of care 15 min

M. Milicevic: Vanishing CRC liver metastases following chemotherapy — what now? 15 min

Daniela Kandioler: To treat or not to treat: MARK53 predicts outcome of cancer patients 15 min

W. Scheithauer: Biologicals in colorectal cancer 15 min

Discussion 15 min

12:30 – 13:00 Hörhager Prize

Irene Kührer: Presentation of 3 best posters

13:00 B. Teleky: Closing remarks


Programm_2013 15.01.13 15:30 Seite 12

13


The congress will provide an extraordinary opportunity for all participantsto meet the leading experts in their fields and network with other collea-gues. A comprehensive list of international speakers will be posted on ourwebsite in due course. Speakers list accepted (October 2012).

• Heinz Becker

• Gina Brown

• Adam Dziki

• Bill Heald

• Jiri Hoch

• Andre D`Hoore

• Zoran Krivokapic

• John Marshall

• Miroslav Milicevic

• Jeffrey Milsom

• Iris Nagtegaal

• John Nicholls

• Mirko Omejc

• Lars Pahlman

• Phil Paty

• Irinel Popescu

• Giovanni Romano

• Evgeny Rybakov

• Yuri Shelygin

• Francis Seow-Choen

• Paul Sugarbaker

• Vincenzo Valentini

• Cornelius van de Velde

• Nir Wasserberg

We also expect numerous speakers from across the world also coming fromUnited States and Asia, giving their specific impact.

For further information and registration visit our homepage:www.efrcancer.org

S P E A K E R

Spea

ker

Programm_2013 15.01.13 15:30 Seite 13

14


T O P I C S A N D G O A L S

T O P I C S :

• Progress in Radiology – New Era of Imaging

• Pathology Implications for Diagnosis, Prognosis and Treatment

• Colorectal Surgery – Techniques, Complication Avoidance and Management

• Improving Interpersonal Communication

• Future Developments in Evidence-Based Medicine

• Changing Concepts in Medical Oncology

• Surgical Management of Colorectal Lung and Liver Metastases

• Comparison of Image-Guided Ablation Techniques

• European Consensus on Radiotherapy

• Quality of Life

G O A L S O F T H E C O N F E R E N C EThe goal of this conference is seen in giving the latest updates concerningthe current techniques of surgical treatment, prognostic factors, and biological therapies in colorectal cancer.

Early detection, imaging methods, preoperative work up, optimum timehandling of multimodal treatment options will be discussed in interactivesessions and round table meetings.

This conference will merge a multidisciplinary group of experts in the fieldof surgery, radiology, radiotherapy, pathology, gastroenterology as wellas oncology. Consensus statements for different open questions will be worked out as an implication of the lively discussions we will expect forcertain.

Top

ics

and

Go

als

Programm_2013 15.01.13 15:30 Seite 14

15

Scientific SecretariatIrene Kührer, MDSecretary General of the EFRVienna/Austriae-mail: [email protected]

RegistrationKuoni Destination Management Austriac/o EFR 2013Andreas ScholtenLerchenfelder Gürtel 43/4/1A-1160 Vienna/AustriaTel.: +43/1/319 76 90-29, Fax: +43/1/319 11 80e-mail: [email protected]

ExhibitionMAW Exhibitions & AdvertisingFreyung 6A-1010 Vienna/AustriaTel.: +43/1/536 63-48, -34, Fax: +43/1/535 60 16e-mail: [email protected]

LocationVienna General Hospital (AKH)HörsaalzentrumWähringer Gürtel 18-20A-1090 Vienna/Austria

AbstractsThe European Federation for ColoRectal Cancer is accepting abstract submissions for poster presentations. The EFR will donate a poster prize forthe best submitted abstract. Abstracts must be submitted online viawww.efrcancer.org. Abstract Guidelines are availabe on the EFR website. Deadline for Abstract submission: December 15th, 2012

G E N E R A L I N F O R M AT I O N

Gen

eral

Info

rmat

ion

Programm_2013 15.01.13 15:30 Seite 15

Programm_2013 15.01.13 15:30 Seite 17

8 INTERNATIONAL EFR CONGRESS VIENNA, AUSTRIA APRIL 4 … · BÉLA TELEKY, MD, FRCS President of the EFR IRENE KÜHRER, MD Secretary General of the EFR Call for Abstracts 8TH INTERNATIONAL

Documents